{
     "PMID": "27703789",
     "OWN": "NLM",
     "STAT": "PubMed-not-MEDLINE",
     "LR": "20170816",
     "IS": "2056-4724 (Print) 2056-4724 (Linking)",
     "VI": "2",
     "IP": "4",
     "DP": "2016 Jul",
     "TI": "Bulking up the hippocampus in schizophrenia: a role for 5-HT1A agonists?",
     "PG": "e10-e11",
     "AB": "SUMMARY: The volume of the hippocampus is reduced in patients with schizophrenia, and this deficit tends to become more pronounced with chronicity. Newer antipsychotics may protect against the progressive reductions in hippocampal volume while preliminary data offer hope that specific antipsychotics may act to reverse it. DECLARATION OF INTEREST: None. COPYRIGHT AND USAGE: (c) The Royal College of Psychiatrists 2016. This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) licence.",
     "FAU": [
          "Frangou, Sophia"
     ],
     "AU": [
          "Frangou S"
     ],
     "AD": ", MD, PhD, FRCPsych, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Editorial"
     ],
     "DEP": "20160712",
     "PL": "England",
     "TA": "BJPsych Open",
     "JT": "BJPsych open",
     "JID": "101667931",
     "PMC": "PMC4995174",
     "EDAT": "2016/10/06 06:00",
     "MHDA": "2016/10/06 06:01",
     "CRDT": [
          "2016/10/06 06:00"
     ],
     "PHST": [
          "2016/05/15 00:00 [received]",
          "2016/06/27 00:00 [revised]",
          "2016/06/28 00:00 [accepted]",
          "2016/10/06 06:00 [entrez]",
          "2016/10/06 06:00 [pubmed]",
          "2016/10/06 06:01 [medline]"
     ],
     "AID": [
          "10.1192/bjpo.bp.116.002857 [doi]",
          "bjporcpsych002857 [pii]"
     ],
     "PST": "epublish",
     "SO": "BJPsych Open. 2016 Jul 12;2(4):e10-e11. doi: 10.1192/bjpo.bp.116.002857. eCollection 2016 Jul.",
     "term": "hippocampus"
}